Shares of CRISPR Therapeutics CRSP have risen 14% over the past month, likely driven by encouraging results from the first ...

Per Schaeffer's Senior Quantitative Analyst Rocky White, CRSP has moved up toward its 260-day moving average. More ...

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $42.94, representing a +2.02% change from its previous close.

Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable ...

Wealth Enhancement Advisory Services LLC lessened its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.7% ...

CRISPR Therapeutics (NasdaqGM:CRSP) experienced a 15.8% increase in its share price over the past month. While specific recent news on the company was not available to credit for this movement, it's ...

Crispr Therapeutics AG ( ($CRSP) ) has risen by 13.29%. Read on to learn why. Crispr Therapeutics AG has seen a notable increase in its stock ...

KRA defends new car valuation, says changes reflect rising market trends and that 2019 prices are outdated; missing models to ...

“The IPO gives Circle broad public recognition for the critical piece of crypto infrastructure they’ve built,” said CoinFund ...

Circle stock rose as much as 235% in its first day as a public company. The stablecoin market is having a moment, also ...

Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.